Inaugural strategy is one of the largest ever first-time private life sciences growth funds Fundraise closed above its original target, reflecting stron...
Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company ded...
Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development...
Tome Biosciences, Inc., the programmable genomic integration (PGI) company, announces that it has acquired Replace Therapeutics Inc., a private biote...
The transformative point of care solution will complement Roche’s centralised diagnostics portfolio across Clinical Chemistry, Immunochemistry, Coa...
Cell BioEngines, Inc., a clinical-stage biotechnology company focused on delivering novel, innovative stem cell and immune cell therapies to address blood ...
Kite, a Gilead Company (Nasdaq: GILD), announced that the U.S. Food and Drug Administration (FDA) has approved a label update for Yescarta® (axicabtage...
Agilent Technologies announced it has moved the company’s Cell Analysis Division into its Diagnostics and Genomics Group (DGG) as part of a strategy ...
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and Akron Bio (“Akron&...
As 2024 nears, the healthcare landscape is undergoing unprecedented transformations, particularly with headlines about artificial intelligence (AI) technol...
Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new i...
Charles River Laboratories International, Inc. announced an important milestone in their strategic collaboration to manufacture CASGEVY™ (...
Friedreich’s ataxia is a genetic, debilitating and life-shortening neuromuscular disease1 Milestone highlights Biogen’s growing portfolio in...
Parse Biosciences, a leading provider of easily accessible and scalable solutions for single-cell sequencing, announced today that the company has raised $...
© 2025 Biopharma Boardroom. All Rights Reserved.
